Additional file 3: Figure S2. of Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD—a randomised controlled study

Salomon, Joerg; Stolz, Daiana; Domenighetti, Guido; Frey, Jean-Georges; Turk, Alexander; Azzola, Andrea; Sigrist, Thomas; Fitting, Jean-William; Schmidt, Ulrich; Geiser, Thomas; Wild, Corinne; Kostikas, Konstantinos; Clemens, Andreas; Brutsche, Martin

doi:10.6084/m9.figshare.c.3663490_D1.v1

12931_2016_498_MOESM3_ESM.pdf (371.73 kB)

Additional file 3: Figure S2. of Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD—a randomised controlled study

journal contribution

posted on 2017-01-11, 05:00 authored by Joerg Salomon, Daiana Stolz, Guido Domenighetti, Jean-Georges Frey, Alexander Turk, Andrea Azzola, Thomas Sigrist, Jean-William Fitting, Ulrich Schmidt, Thomas Geiser, Corinne Wild, Konstantinos Kostikas, Andreas Clemens, Martin Brutsche

Forced expiratory volume in 1 s (FEV1) [L] – pooled analysis of SYNERGY, SHINE and GLOW6 (N = 1503). (PDF 371 kb)

Funding

Novartis Pharma AG, Switzerland

History

Usage metrics

Keywords

COPD Indacaterol Glycopyrronium Spirometry Body plethysmography

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 3: Figure S2. of Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD—a randomised controlled study

Funding

Novartis Pharma AG, Switzerland

History

Usage metrics

Categories

Keywords

Licence

Exports